SCR-1481B1

Names

[ Name ]:
SCR-1481B1

Biological Activity

[Description]:

SCR-1481B1 (c-Met inhibitor 2) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor.

[Related Catalog]:

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR

Research Areas >> Cancer

[Target]

VEGFR1

[In Vitro]

More details please refer to Patent WO 2009094417 A1.

[References]

[1]. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.

[Related Small Molecules]

Nintedanib (BIBF 1120) | SU5416 | Apatinib Mesylate | PD173074 | Capmatinib (INCB28060) | Foretinib (GSK1363089) | PHA-665752 | SU 5402 | Linifanib (ABT-869) | Cediranib | Lucitanib | RAF265 (CHIR-265) | LY2784544 | BMS-777607 | SU14813

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₈H₂₉ClF₂N₅O₁₀P

[ Molecular Weight ]:
699.98

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.